The Desmoid Tumor Research Foundation

“Tumor volume and T2 hyperintensity changes from DeFi: a phase 3, randomized, controlled trial of nirogacestat in patients with desmoid tumors”

Events

by

Recorded at the 2023 DTRF Int’l Desmoid Tumor Research Workshop

by

Recorded at the 2023 DTRF Int’l Desmoid Tumor Research Workshop

by

Recorded at the 2023 DTRF Int’l Desmoid Tumor Research Workshop

by

Recorded at the 2023 DTRF Int’l Desmoid Tumor Research Workshop

by

by